PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9843724-4	1998	Drug competition studies with various monoamine uptake inhibitors gave rise to complex multiphasic displacement curves, although the results obtained with the selective 5-HT uptake inhibitor citalopram suggest that the 5-HT transporter is an important component of placental high-affinity [125I]RTI-55 binding.	monoamine	38-47	solute carrier family 6 member 4	Rattus norvegicus	219-235	
29697951-1	2018	4-Methylamphetamine (4-MA) is an emerging drug of abuse that acts as a substrate at plasma membrane transporters for dopamine (DAT), norepinephrine (NET), and serotonin (SERT), thereby causing nonexocytotic release of monoamine transmitters via reverse transport.	monoamine	218-227	solute carrier family 6 member 4	Rattus norvegicus	170-174	
29976854-3	2018	administered LPS increased extracellular monoamine metabolite levels in the nucleus accumbens (NAc) and medial prefrontal cortex (mPFC), which was completely, or at least partly, prevented by pretreatment with a triple reuptake inhibitor that also blocks the serotonin (5-HT) transporter (SERT).	monoamine	41-50	solute carrier family 6 member 4	Rattus norvegicus	289-293	
24821570-4	2014	Sibutramine occupied monoamine reuptake binding sites with the rank order of potency of NET>SERT>DAT; at 10mg/kg, po, occupancy was 95% NET, 81% SERT and 73% DAT.	monoamine	21-30	solute carrier family 6 member 4	Rattus norvegicus	95-99	
10685879-10	2000	Kinetic analysis of monoamine uptake inhibition by procaine in COS cells expressing rat DAT, NET or SERT revealed a competitive action similar to that of cocaine.	monoamine	20-29	solute carrier family 6 member 4	Rattus norvegicus	100-104	
25438806-6	2015	KEY RESULTS: MCAT and all six para-substituted analogues increased monoamine release via DAT and SERT and dose- and time-dependently modulated ICSS.	monoamine	67-76	solute carrier family 6 member 4	Rattus norvegicus	97-101